Aquinox Pharmaceuticals Inc.

Available to platforms
R StocksTrader

Aquinox Pharmaceuticals Inc. (AQXP) on the NASDAQ Exchange

Company overview

Aquinox Pharmaceuticals Inc. is a publicly listed company from USA with shares traded on NASDAQ under the ticker AQXP. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for AQXP are bid 3.6 USD and ask 3.74 USD.

Use the chart to review recent momentum, identify key price areas, and track how Aquinox Pharmaceuticals Inc. is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add AQXP to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: Aquinox Pharmaceuticals Inc.
  • Ticker: AQXP
  • Country: USA
  • Bid3.6 USD
  • Ask3.74 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of AQXP does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Aquinox Pharmaceuticals Inc. (AQXP) in R StocksTrader. Create and verify your profile, fund the account, search for AQXP, and choose the instrument type available to you. Add AQXP to your Watchlist to track moves and manage open positions throughout 2025.

AQXP trades on NASDAQ and is issued by Aquinox Pharmaceuticals Inc.. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for AQXP match your plan.

Quotes update automatically in real time. Current levels for AQXP are bid 3.6 USD and ask 3.74 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track AQXP in R StocksTrader and adjust your approach as market conditions change in 2025.